INTRODUCTION
The discovery of protein biomarkers enables the early detection and accurate prognosis of many diseases (1) . The ability to specifically detect and identify protein expression also helps determine the responses of an organism and/or host immune system to treatment. Many conventional methods of protein detection are based on the enzyme-linked immunosorbent assay (ELISA), measuring specific interaction between target proteins and antibodies immobilized on a solid support. However, conventional ELISA requires significant starting materials, so considerable research is directed toward miniaturizing ELISA-based techniques in the form of protein arrays (2) (3) (4) . Antibody arrays detect changes in protein expression and, in this sense, are analogous to DNA arrays for gene expression analysis. Proteins are either labeled with fluorescent dye before applying to the chip or detected with a second antibody, specific to a different region of the molecule. Such ELISAtype sandwich immunoassays require a rigorous selection of a matched pair of capture and detection antibodies recognizing different parts of the protein with little or no spatial interference.
Similarly, drug discovery depends on designing effective inhibitors of protein function. Drug candidates have to be selected for their effect on the target protein in either activity or binding assays. Microarrays provide a high-throughput platform for screening drug candidates (5) . However, affinity reagents used for signal detection in conventional arrays require a priori knowledge of interacting partners and therefore are not suitable for detecting interactions with uncharacterized, modified, or novel interacting molecules. Because affinity-based signal detection techniques cannot unambiguously distinguish specific interactions from nonspecifically bound proteins, the detection selectivity suffers from crossreactivity of affinity reagents, resulting in high background levels, which limits the number of individual reactions in one assay. Alternative methods to label or tag each sample may change its activity and biochemical properties (6, 7) . Thus, detecting macromolecules and characterizing their interactions, especially in complex mixtures (e.g., cell lysates, serum, and environmental samples), ultimately require indicator-free methods (8) that offer the potential to simultaneously detect uncharacterized molecules bound to the probe.
Mass spectrometry is capable of detecting many proteins simultaneously by identifying their molecular masses and does not necessarily require labeling or "tagging" analyte molecules. Several ionization methods such as fast atom bombardment (9) , matrix-assisted laser desorption and ionization (MAL-DI) (10) , and electrospray ionization (ESI) (11) are used as ion sources for mass spectrometry. MALDI is a wellestablished mass spectometry ionization technique and is accomplished by co-dispersing and crystallizing probes with a laser-absorbing matrix [e.g., sinapinic acid (SA), α-cyano-4-hydroxycinnamic acid (α-CHC), 2,5-dihydroxybenzoic acid (DHB) 
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probe introduction for ESI). A similar ionization technique is used by the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), a ProteinChip ® system now sold by Ciphergen (Fremont, CA, USA) that is capable of detecting proteins bound to lowdensity, planar chromatographic, or protein arrays (12) . MALDI-MS has also been combined with surface plasmon resonance technology (13) . However, planar chip surfaces are known to denature proteins and induce steric constraints on binding and protein function (14, 15) , and a 2-dimensional (2-D) surface has a characteristic (and relatively low) binding capacity that may affect lower detection limits and the linear dynamic range of the overall system.
Three-dimensional (3-D) gels were developed, in part, to overcome steric and probe density constraints imposed by 2-D surfaces while preserving the functional integrity of immobilized biomolecules (16) (17) (18) (19) . Recently, MALDI-MS has been used to demonstrate the feasibility of detecting proteins bound to 3-D acrylamide-based gel-pad arrays (20) as well as to continuous HydroGel ® protein arrays (Perkin Elmer, Wellelsey, MA, USA) (21) . A common criticism of gel substrates is the potentially restricted pore size of the matrix (3, 22) because small pores can limit diffusion and preclude large molecules from entering into the gel and forming complexes with the immobilized probe. To address the pore size constraints and improve the range of applications for 3-D microarrays, we are studying new polymers in which the porosity can be varied from tens to hundreds of nanometers. These new polymer matrices improve macromolecular diffusion in a mechanically, thermally, and chemically stable array element. The purpose of this study was therefore to develop a new 3-D MALDI-MS protein microchip for high-throughput detection, identification, and characterization of protein-protein interactions and activity in uncharacterized or complex biological backgrounds. The microchips incorporate a new 3-D element polymer that interfaces directly with a commercially available MALDI mass spectrometer.
MATERIALS AND METHODS

Biochip Fabrication
Photopolymerized methacrylate element arrays were manufactured as described by Yershov et al. (23) , with the following modifications. A photopolymerization mixture of glycidyl methacrylate (GMA), ethylene dimethacrylate (EDMA), N-(5,6-di-o-isopropylidene) hexylacrylamide, and 2,2-dimethoxy-2-phenyl-acetophenone (Aldrich, Milwaukee, WI, USA) was prepared by first mixing 20% N-(5,6-di-o-isopropylidene) hexylacrylamide in GMA in a 6:4 (v/v) ratio with EDMA. The resulting solution was then mixed with cyclohexanol-dodecanol [9:1 (v/v)] in a ratio of 4:6 (v/v). Three microliters of 10% (w/v) 2,2-dimethoxy-2-phenylacetophenone in cyclohexanol were added to 100 μL of the combined polymer solution, vortex mixed, and degassed for 3 min. Next, a polymerization chamber was assembled consisting of either a no. 1½ rectangle microscope cover glass or glass microscope slide (Corning Life Sciences, Acton, MA, USA), treated with PlusOne™ BindSilane (Amersham Biosciences, Uppsala, Sweden), and a chromium-plated quartz mask containing transparent windows arranged in 200 × 200-μm squares on 2-mm centers. The polymerization chamber was filled with the activated polymer mixture and exposed to a UV light from an Oriel UV Flood Exposure Source with 6 × 6 beam of light (Oriel Instruments, Stratford, CT, USA) powered by a 1000 W HgXe lamp for 5 min. After photopolymerization, the chamber was disassembled, and the polymerized 3-D array matrix was briefly rinsed with ethanol and water, washed in methanol for 30 min in methanol-water solution [1:1 (v/v)] for 30 min, and then air-dried. The microchip matrices can be stored dried at room temperature for at least 1 year.
Protein Immobilization
Proteins were immobilized to the polymer backbone by covalently coupling protein amines with aldehyde groups in the polymer. Aldehyde groups were generated from GMA epoxide moieties in the array elements by incubating array polymer matrices in 0.5 M boron trifluoride etherate in ethanol-water [9:1 (v/v)] for 3 h. After washing with ethanol and water for 5 min, the matrices were treated with 2% trifluoroacetic acid for 15 min and rinsed with water for 5 min. Finally, the matrices were treated with 0.1 M sodium periodate for 30 min, rinsed with water, and dried.
Individual array elements were manually loaded with approximately 0.2 μL of 100 μM protein in immobilization buffer (0.1 M NaCl, 10 mM sodium phosphate, pH 7.0, and 10% glycerol) corresponding to approximately 500× the 3-D volume of an individual element. The chip was then incubated overnight in a sealed humid chamber containing a saturated solution of sodium chloride. Schiff bases (formed by the reaction of aldehyde groups in the polymer with protein amines) and remaining reactive aldehyde groups were reduced with 0.1 M sodium borohydride for 5 min, resulting in a stable covalent bond between the protein and the polymer matrix. Protein arrays were then rinsed once with Trisbuffered saline (TBS; Pierce, Rockford, IL, USA) for 10 min, three consecutive washes with TBS plus 0.1% Tween ® 20 (TBST) for 10 min each, and Superblock™ solution in TBS (Pierce) for 1 h.
Protein immobilization on SuperAldehyde (Telechem International, Sunnyvale, CA, USA) and HydroGel substrates were carried out according to the manufacturers' recommendations. For direct comparisons between MALDI-MS arrays and the commercial substrates, the arrays were fabricated on a standard glass microscope slide, as described above, rather than on a glass coverslip.
Interaction Assays and MALDI-MS Analysis
Interaction assays between the protein arrays and target solutions were normally carried out in TBST in 20 or 200 μL CoverWell™ incubation chambers (Grace Biolabs, Bend, OR, USA) for 2 h at room temperature. Unbound protein was removed by three consecutive washes with TBST for 10 min at room temperature; the array was brief-ly rinsed with water and air-dried. Two hundred nanoliters of MALDI matrix solution were then manually applied to each array element, and the array was air-dried and mounted directly onto a ground steel MALDI target MTP 384 TF (Bruker Daltonics, Billerica, MA, USA). The choice of MALDI matrix was determined in preliminary experiments where the application of α-CHC resulted in higher signal intensity compared to other matrices, such as SA or DHB (data not shown). For protein arrays that were fabricated on commercially available substrates (coated glass microscope slides), we machined a 1-mm depression in an aluminum massive target MTP 384 T to maintain laser focus with the surface of the biochip. The plate was introduced into a Biflex™ III mass spectrometer (Bruker Daltonics), and the mass spectrum from each array element was individually obtained according to the manufacturers' instructions. Normally, the signal was taken from 200 laser shots per array element from at least five replicate elements. Each experiment was repeated at least twice.
MALDI-MS Analysis of On-Chip Protein Activity
Trypsin was immobilized in MALDI-MS array elements as described above and incubated overnight in a sealed chamber at 37°C with 5 μL of 10 μM apomyoglobin (Sigma, St. Louis, MO, USA) in 10 mM ammonium acetate, pH 6.0. Identical reactions were also performed in parallel with 1 μM trypsin in standard 1.5-mL polypropylene microcentrifuge tubes. Afterwards, 2 volumes of α-CHC MALDI matrix solution were added to 1 volume of reaction mixture, 0.5 μL of the mixture was transferred to the mass spectrometer target plate, dried, and analyzed with the mass spectrometer. Signal was taken from 200 laser shots per spot and from at least five spots on the MALDI plate. The experiment was repeated three times.
Protein Interaction Assay in a Cell Lysate
Human embryonic kidney (HEK)293 cells were cultured in plastic dishes (BD Biosciences, Franklin Lakes, NJ, USA) in Dulbecco's modified Eagle's medium (DMEM) medium supplemented with 10% heatinactivated fetal bovine serum (FBS; HyClone, Logan, UT, USA). The cells were incubated at 37°C in humidified air containing 8% CO 2 . The cells were washed twice with ice-cold phosphatebuffered saline (PBS) and scraped from the bottom of the plate. The cells were collected by centrifugation at 500× g for 3 min and then incubated at -20°C for 2 h. An equal volume (normally 0.2-0.5 mL) of homogenization buffer [10 mM Tris-HCl, pH 7.4, 250 mM sucrose, 2 mM EDTA supplemented with the proteinase inhibitor cocktail, 0.1 mg/mL N-p-tosyl-L-phenylalanine chloromethyl ketone (TPCK), 0.1 mg/mL phenylmethylsulfonyl fluoride (PMSF), 1 μg/mL pepstatin, 1 μg/mL leupeptin, 2 μg/mL antipain] was added to the cell pellet, and the mixture was homogenized with a Dounce homogenizer (tight fit). The cell lysate was cleared by centrifugation at 100,000× g for 1 h and supplemented with trypsin (Sigma) at the indicated concentrations. The mixtures were then hybridized to the soybean trypsin inhibitor (STI; Sigma) immobilized on the chip, and the bound protein was detected with mass spectrometry as described above.
On-Chip Immunoassays
Anti-human IL-1α monoclonal antibodies (Pierce) and mouse monoclonal anti-human TNF-α antibodies MAB1 (eBioscience, San Diego, CA, USA) were immobilized within array elements using 1 mg/mL stock solution. Protein arrays were then hybridized to either Texas Red-modified goat antimouse IgG (Molecular Probes, Eugene, OR, USA) or to RPMI 1640 medium supplemented with 10% heat-inactivated FBS (Harlan, Indianapolis, IN, USA), 100 μg/mL penicillin, 100 μg/mL streptomycin (Invitrogen, Rockville, MD, USA), and recombinant TNF-α (eBioscience) as described above.
RESULTS
MALDI-MS Biochip Templates
The MALDI-MS biochip template represents a high-density array of GMA polymer elements (typically 200 × 200 μm) photopolymerized on a 0.17-mm thin glass microscope coverslip in various patterns (the layout for manual loading is shown in Figure 1 ). Due to the smaller size of an individual element, the density of MALDI-MS chip elements is much higher than that of commercial SELDI or Biacore chips (Biacore AB, Uppsala, Sweden). Many biochip applications in our laboratory use other high-density layouts, accommodating thousands of elements on one chip. Probe loading to these chips is accomplished with an ANL custom-built, multipin robot (Quadrate II) specifically designed to load probes on preformed, three-dimensional gel element features without direct pin contact with the gel elements (see U.S. Patent nos. 5,851,776; 5,851,783 and related patents). The ANL production facility has the capacity for 1000 biochips per month.
The hydrophobic separation between array elements prevents probe diffusion or mixing between test sites and allows repeated application of the probe without "spreading" and mixing probes. Our interest in methacrylate polymers stems from recent data showing that the methacrylate formulation increases protein binding capacity at least 5-to 7-fold compared to acrylamide substrates (A. Kukhtin, B. Chernov, J. Golova, G. Yershov, and M. Gemmell, unpublished data). Unlike acrylamide, methacrylate did not require hydration prior to protein immobilization, which provides a modest simplification 
MALDI-MS Detection of OnChip Trypsin-Trypsin Inhibitor Interactions
The well-characterized functional interactions between bovine trypsin and trypsin inhibitors (24-26) were used to develop protein immobilization protocols, probe hybridization and washing conditions, and an analytical procedure for mass spectral detection of hybridized proteins. As shown in Figure 2 , the MALDI-MS biochip system was able to detect the specific interaction between bovine pancreatic trypsin (BPT) and STI [association constant K a = 10 10 M -1 (27)] regardless of which protein was immobilized in the array elements (Figure 2 , A and C), indicating that specific functional interactions can occur within the methacrylate element array. To determine if the MALDI-MS arrays can be used to physically separate weakly interacting partners, we performed an identical experiment using the on-chip association of trypsin with SPC1 trypsin inhibitor [K a = 10 6 M -1 (28)]. Trypsin binding to immobilized inhibitor SPC1 was detected ( Figure 2D ), which shows that the MALDI-MS biochip system can also be used to interrogate lower affinity protein interactions. Control reactions between STI and immobilized bovine serum albumin (BSA; Figure 2B ) and the application of MALDI matrix to a blank methacrylate element array incubated with trypsin ( Figure 2E ) resulted in no detectable signal, which suggests that the methacrylate polymer element formulation is relatively immune to nonspecific protein binding. The absence of any signal corresponding to the immobilized protein ( Figure  2 , A and C) demonstrates that polymerimmobilized protein or capture probe is not released from the array element during laser desorption and ionization.
Detecting on-chip protein interactions is not equivalent to detecting or characterizing protein function. Indeed, covalently attaching proteins to a surface often results in a loss of biological activity (3, 4, 22, 29) . To determine if trypsin immobilization to the methacrylate polymer also retains protein activity, trypsin was immobilized in methacrylate element arrays and incubated with 10 μM apomyoglobin overnight at 37°C. As shown in Figure 3 , the spectrum of products of apomyoglobin proteolysis by immobilized trypsin was similar to the spectrum obtained from a test-tube control reaction even though lower signal was detected in the case of the on-chip reaction. However, the absence of partial digestion products in the spectra suggests that the proteolysis was completed in both samples and indicates that protein immobilization within the methacrylate polymer element did not destroy enzyme function and activity. 
SPC1 trypsin inhibitor, or to (E) an empty element (i.e., negative control) are shown. The probes were immobilized in the array elements of the same chip by loading 10 mg/mL stock solutions to 5-10 array elements. Each chip was hybridized to either (A and B) 10 μg/mL STI or (C-E) 1 μg/mL trypsin. Each mass spectrum corresponds to 200 laser shots per element and is the representative signal from at least five elements in at least three hybrization experiments performed with different chips. BSA, bovine serum albumin; STI, soybean trypsin inhibitor; a.i., absolute intensity; m/z, mass-to-charge ratio.
To determine if methacrylate array elements could be used to spatially isolate interacting partners in cell extracts, various concentrations of STI were added to HEK293 cell lysates and hybridized to polymer-immobilized bovine trypsin. As shown in Figure 4 , the prototype MALDI-MS biochip system can specifically detect as little as 1.5 pM of total STI amount in the cell lysate. These data demonstrate that the methacrylate polymer element array can be utilized as an affinity purification platform for MALDI-MS analysis of proteins and interacting partners in biological samples of various complexities.
Biochip Substrates
MALDI-MS-based detection techniques can certainly be used in combination with planar (12,13) and continuous HydroGel (21) substrates. We hypothesized that discrete methacrylate polymer elements will provide higher probe immobilization capacity and, thus, improved detection limits and/or dynamic range than other substrates. To begin addressing this hypothesis, we performed a comparison between commercially available microarray substrates and the methacrylate element arrays developed and described here. TeleChem International's SuperAldehyde slides were utilized as a template for planar arrays because the protein immobilization chemistry is similar to the one used for the methacrylate polymer described here. Perkin Elmer's 3-D acrylamide-based HydroGel has been shown to be conducive to on-chip MALDI-MS analysis (21) and represents a commercially available 3-D surface. Because both SuperAldehyde and HydroGel surface chemistries are deposited on glass microscope slides, we likewise manufactured the methacrylate element arrays on glass slides for these experiments.
STI was immobilized at various concentrations, and the respective arrays were hybridized to trypsin solution. As shown in Figure 5A , the planar substrate did not produce any detectable signal even at the highest concentration of immobilized capture protein.
These results suggest that the planar surface is either denaturing trypsin, orienting trypsin in a sterically unfavorable manner for interaction, providing limited probe binding capacity, or any combination thereof. At the same time, both the continuous HydroGel ( Figure  5B ) and methacrylate element ( Figure  5C ) arrays generated detectable signal. However, the methacrylate elements generated more intense signal than continuous HydroGel. The improved signal of methacrylate elements relative to continuous HydroGel suggests that the methacrylate elements are providing a higher probe-loading capacity (thus improved capacity for interaction) than continuous HydroGel or that the methacrylate polymer formulation provides better binding conditions than acrylamide. Both interpretations are consistent with higher immobilization capacity and detection limits of methacrylate element-based antibody arrays measured with fluorescent detection techniques (A. Kukhtin, B. Chernov, J. Golova, G. Yershov, and M. Gemmell, unpublished data).
On-Chip Immunoassays
As discussed earlier, selective labeling of analyte molecules may not be possible in clinical or environmental samples; therefore, many protein array platforms use affinity reagents such as antibodies or aptamers to detect bound proteins. Many of these molecules are cross-reactive, and their mixing in one assay increases nonspecific binding, which in turn decreases the selectivity of protein detection. At the same time, mass spectrometry can easily discriminate the target protein from other proteins bound to the same array element. Application of the MALDI-MS-based signal readout in protein expression profiling would eliminate the need for detection antibodies, thus a large number of target molecules can be detected in one assay. To explore the extensibility of methacrylate biochips to im- munoassay-based applications, we investigated whether antibodies can be used as either a capture probe or an interacting partner in the MALDI-MS biochip system. For these experiments, anti-human interleukin-1α (IL-1α) monoclonal antibodies were immobilized in methacrylate 3-D elements and hybridized to various concentrations of Texas Red-modified goat anti-mouse antibody. Standard fluorescent imaging of the hybridized biochip was used to confirm the specific interaction of the Texas Red immunoglobulin G (IgG) with immobilized IL-1α antibodies (data not shown). As shown in Figure 6 , the MALDI-MS biochip system detected binding of anti-mouse antibodies at concentrations higher than 7 nM. These data show that large molecules (up to 150 kDa) not only enter the methacrylate polymer element and interact with binding partners, but that they can also be ablated from the 3-D elements and detected as intact protein masses. The demonstrated ability to use antibodies as capture agents makes it possible to use MALDI-MS biochips in lieu of conventional (and crossreactive) immunoassay microarrays. For example, antibody arrays are proving useful for cytokine profiling to determine the immune response of the cells (30). To test the applicability of the MALDI-MS biochip platform to cytokine detection, we determined the lowest concentration of the TNF-α cytokine in cell culture medium that can be detected with the MALDI-MS biochip system. We also compared the performance of three biochip platforms: methacrylate, acrylamide (16) , and HydroGel biochips in this type of assay. The anti-human TNF-α monoclonal capture antibody MAB1 was immobilized on the slides and hybridized to unpurified cell culture medium containing human recombinant TNF-α at various concentrations. As shown in Figure 7 , a concentration-dependent peak corresponding to the secreted form of TNF-α is observed at concentrations higher than 1 ng/mL for methacrylate and acrylamide arrays ( Figure 7 , A and B) and higher than 10 ng/mL for HydroGel slides (Figure7C). Methacrylate biochips detected as little as 20 fM of total TNF-α amount in 10 7 excess of cell culture medium proteins (w/w) and generated the highest signal among the microarray substrates, even amid nonspecific interactions between proteins present in the cell medium and the array elements. These data correlate with the increased protein binding capacity of methacrylate chips compared to other platforms observed with mass spectrometry ( Figure 5 ) and optical signal detection (A. Kukhtin, B. Chernov, J. Golova, G. Yershov, and M. Gemmell, unpublished data). These experiments also demonstrate the feasibility of using methacrylate MALDI-MS biochips for antibody-based protein expression profiling. Several opportunities for increasing MALDI-MS biochip detection limits and decreasing nonspecific binding to methacrylate polymer elements are available and are the topic of ongoing research.
DISCUSSION
In this study, we describe the use of a new methacrylate polymer for fabricating 3-D element protein arrays and demonstrate the utility of methacrylate element protein arrays as an affinity separation chip for MALDI-MS analysis of protein interactions. Mass spectrometry clearly offers the opportunity to detect proteins and identify their molecular masses without a priori knowledge of protein expression or generating affinity reagents for detecting each target of interest. SELDI-MS, in particular, is a well-known, commercially available platform for chromatographic separations and protein detection on 2-D surfaces, but interaction assays on planar substrates are subject to the limitations of 2-D surfaces, as previously described in detail (14) and illustrated in Figure 5A . At the same time, the current SELDI platform offers limited multiplexing capacity in a homogenous assay (six spots per a chip), a potentially significant limitation for deciphering molecular networks and complexes at the whole-proteome scale. Moreover, the relatively high (capital and operating) expense of commercial systems precludes their use by investigators who do not run binding assays on a regular basis. The 3-D element microchips, on the other hand, can be manufactured in-house at a relatively low cost and can be interfaced with virtually any offthe-shelf mass spectrometer without modifying the instrument. The promise and potential of 3-D biochip substrates is that they will overcome the steric and probe immobilization capacity constraints of planar biochips, while preserving biomolecular integrity, function, and activity. Early studies demonstrated the feasibility of using mass spectrometry to detect hybridization signal from acrylamidebased protein chips (20, 21) . As shown here ( Figures 5 and 7) , however, planar glass, acrylamide, and HydroGel substrates have a lower MS-based detection sensitivity (and/or protein binding capacity) than methacrylate, a potential limitation for detecting weak interactions. The data further show that a 3-D methacrylate polymer element array preserves the functional integrity and biochemical activity of immobilized biomolecules (Figure 3) , providing a clear path for developing comprehensive protein arrays for functional interaction and activity mapping as opposed to simply detecting a (specific or nonspecific) binding event.
Applying the MALDI-MS protein array technology to multiplex protein profiling in biological fluids may also alleviate many drawbacks of the conventional antibody arrays using optical detectors. That is, a multiplexed antibody or ELISA array assumes that all interactions between target and cognate antibody are absolutely specific, an assumption that may or may not be valid (6, 7) . As illustrated in Figures 4 and 7 , the identification of molecular masses of spatially captured proteins from complex mixtures (e.g., cell lysates, serum, and environmental samples) will eliminate the need for specific detection antibodies and will allow protein expression analysis to be carried out with virtually an unlimited number of probes regardless of a priori knowledge or occurrence of interacting partners. Although less sensitive than conventional ELISA, the MALDI-MS biochip analysis did read through the complex background and any nonspecific binding of molecules in the TNF-α assay (Figure 7) , which affords the opportunity to unambiguously detect proteins specifically interacting with each of the immobilized capture probes by identifying their molecular masses. From this perspective, relatively nonspecific antibodies, capture probes, and/or interacting partners can therefore be used in principle as capture molecules in methacrylate polymer element arrays for affinity-based separations prior to mass spectrometry detection, a capability that will facilitate the development and analysis of whole-proteome chips (15) .
On-chip signal detection by MALDI-MS clearly offers an oppor- [ To purchase reprints of this article, contact apfeffer@BioTechniques.com tunity to obtain sequence information on proteins by identifying products of proteolysis of analyzed proteins with sequence-specific proteases or by chemical cleavage (31). Proteins can be identified either by sequencing corresponding peptides with tandem mass spectrometry or by matching peptide masses with masses of predicted products of proteolysis of known proteins in the database (peptide fingerprinting). Further development of the mass spectrometry biochip as a high-throughput platform for the identification of molecules interacting with proteins of interest will facilitate the functional characterization of complete proteomes and the understanding of the role of every protein in the cell.
